RE:RE:RE:RE:RE:my last two cents on this board"Old Stinzo has a point though, nothing has ever come of the endless circular talking on this forum."
It's almost criminal to say that.
Nothing ever comes of it?
Only absolutely blowout CoQ10 bioavailability data against the current gold standard that is so far above anyone's expectations it is jaw-dropping. It even smashed PGX-OBG which only had a limitation of cost as informed by industry. Something very unusual is going on given the results are so extraordinary. CZO may be 'hijacking' macrophages and turning macrophages into a second delivery system creating whole new and substantial opportunities. CZO is now looking to license a life sciences company! Much more than an energy drink!
Nothing ever comes of it?
Only a McMaster team that has expressed excitement about PGX-YBG and the fibrosis opportunity with a decision to go to clinical trials expected in the second half. The team at McMaster has clout and Dr. Ask is now a lead researcher with the second largest pharma in the world, Novartis! He has published with Boehringer Ingleheim's scientists on nintedanib which is one of two standards-of-care for IPF.
Nothing ever comes of it?
Only yeast beta glucan that could set a new standard in the industry that is 5 times more immune stimulatory than the competition.
Nothing ever comes of it?
Only a stock that smashed the S&P Biotech ETF over the last year. CZO is up 43.75% vs. the S&P Biotech only up 4.75%. All this despite small cap biotech being particularily hard hit in the worst biotech bear market in history. CZO's extraordinary pipeline is not even priced into the stock!
Some were only made to read the headlines some were made to anticipate them!